Rahadian Indarto Susilo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Rahadian Indarto Susilo has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Achmad Fahmi
Department of Neurosurgery, Faculty of Medicine, Universitas Airlangga, Dr. Soetomo General Academic Hospital, Surabaya, Indonesia
4 shared publications - Asra Al Fauzi
Department of Neurosurgery, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia
4 shared publications - Irwan Barlian Immadoel Haq
Department of Neurosurgery, Faculty of Medicine, Universitas Airlangga, Indonesia; Dr. Soetomo General Academic Hospital, Indonesia
4 shared publications - Budi Utomo
Universitas Airlangga
3 shared publications - Agus Turchan
Department of Neurosurgery, Dr.Soetomo General Academic Hospital, Surabaya, Indonesia, Surabaya, Indonesia
2 shared publications - Erica Medina Ramadhaningtyas
Department of Neurosurgery, Faculty of Medicine, Universitas Airlangga – Dr. Soetomo Academic General Hospital, Surabaya, Indonesia
2 shared publications
Latest Publications
- Open Access
- 5 October 2026
- Published by Springer Nature in The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
- Vol. 62 (1) , 196
Clinical accuracy and efficiency of augmented reality head-mounted displays in cranial neurosurgery: a systematic review
Background: Augmented Reality (AR) integrates virtual anatomical information into the real-world environment in real time and has emerged as a promising navigation adjunct in cranial neurosurgery. Compared with conventional neuronavigation (CN), AR Head-Mounted Display (HMD) systems project patient-specific anatomy directly into the surgeon’s field of view, potentially improving spatial perception, ergonomics, and surgical workflow. However, their clinical performance remains uncertain because the available evidence is limited and methodologically heterogeneous. This systematic review synthesizes the accuracy and efficiency of AR HMD in cranial neurosurgical procedures. Methods: A systematic review was conducted according to PRISMA guidelines. PubMed, Scopus, and ScienceDirect were searched for prospective clinical studies comparing AR HMD with conventional neuronavigation or reporting quantitative accuracy and/or efficiency outcomes in cranial neurosurgery. Results: Nine prospective non-randomized studies involving 186 patients were included. Accuracy was assessed using registration error, deviation error, percent overlap, and subjective or objective evaluations. Among the five studies reporting registration accuracy, registration error ranged from 1.86 to 4.4 mm. Deviation errors were approximately 4 mm, and spatial congruence exceeded 65%. Subjective and objective assessments also demonstrated favorable anatomical localization and lesion visualization. Efficiency outcomes included registration, setup, planning, and navigation time. Registration time ranged from 2.6 to 7.95 min. Among five comparative studies, two reported shorter procedural times with AR HMD, one reported comparable time, and two reported longer times than conventional neuronavigation. Conclusion: AR HMD technology is a promising adjunct for cranial neurosurgical navigation, providing clinically useful accuracy comparable to conventional neuronavigation in selected applications while improving spatial orientation, ergonomics, and surgical workflow. Current systems should be regarded as complementary rather than replacement technologies and appear most suitable for cranial procedures requiring low to moderate precision navigation. Further prospective multicenter studies with standardized validation protocols and continued technological refinement are needed before widespread clinical adoption.
- 5 October 2026
- Published by Springer Nature in The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
- Vol. 62 (1) , 196
Open AccessClinical accuracy and efficiency of augmented reality head-mounted displays in cranial neurosurgery: a systematic review
Background: Augmented Reality (AR) integrates virtual anatomical information into the real-world environment in real time and has emerged as a promising navigation adjunct in cranial neurosurgery. Compared with conventional neuronavigation (CN), AR Head-Mounted Display (HMD) systems project patient-specific anatomy directly into the surgeon’s field of view, potentially improving spatial perception, ergonomics, and surgical workflow. However, their clinical performance remains uncertain because the available evidence is limited and methodologically heterogeneous. This systematic review synthesizes the accuracy and efficiency of AR HMD in cranial neurosurgical procedures. Methods: A systematic review was conducted according to PRISMA guidelines. PubMed, Scopus, and ScienceDirect were searched for prospective clinical studies comparing AR HMD with conventional neuronavigation or reporting quantitative accuracy and/or efficiency outcomes in cranial neurosurgery. Results: Nine prospective non-randomized studies involving 186 patients were included. Accuracy was assessed using registration error, deviation error, percent overlap, and subjective or objective evaluations. Among the five studies reporting registration accuracy, registration error ranged from 1.86 to 4.4 mm. Deviation errors were approximately 4 mm, and spatial congruence exceeded 65%. Subjective and objective assessments also demonstrated favorable anatomical localization and lesion visualization. Efficiency outcomes included registration, setup, planning, and navigation time. Registration time ranged from 2.6 to 7.95 min. Among five comparative studies, two reported shorter procedural times with AR HMD, one reported comparable time, and two reported longer times than conventional neuronavigation. Conclusion: AR HMD technology is a promising adjunct for cranial neurosurgical navigation, providing clinically useful accuracy comparable to conventional neuronavigation in selected applications while improving spatial orientation, ergonomics, and surgical workflow. Current systems should be regarded as complementary rather than replacement technologies and appear most suitable for cranial procedures requiring low to moderate precision navigation. Further prospective multicenter studies with standardized validation protocols and continued technological refinement are needed before widespread clinical adoption.
- Open Access
- 22 July 2026
- Published by Springer Nature in BMC Medical Education
- Vol. 26 (1)
Cross-cultural adaptation and validation of the Indonesian version of the operating room educational environment measure with Indonesian residents
- 22 July 2026
- Published by Springer Nature in BMC Medical Education
- Vol. 26 (1)
Open AccessCross-cultural adaptation and validation of the Indonesian version of the operating room educational environment measure with Indonesian residents
- 18 January 2026
- Published by SAGE Publications in The International Journal of Artificial Organs
- Vol. 49 (1) , 47-54
Biocompatibility of heparin-coated PLLA-chitosan patch potentially usable for large blood vessel reconstruction: A Wistar rat histological study
Introduction: Stroke remains a leading cause of disability and death globally, with carotid stenosis as a major contributor. Carotid endarterectomy with patch angioplasty reduces restenosis risk, but current patch materials often lack biocompatibility and biodegradability. This study introduces a novel vascular patch composed of poly-L-lactic acid (PLLA) and chitosan, coated with heparin, designed to promote tissue integration and safe degradation. Method: A true experimental in vivo study was conducted using 54 Wistar rats, divided into three groups: (1) PLLA scaffold (Group K1/K2), (2) PLLA-chitosan scaffold (Group P1/P3), and (3) PLLA-chitosan with heparin coating scaffold (Group P2/P4). Histological analyses at 14 and 56 days post-implantation evaluated inflammatory response, fibrous capsule formation, and angiogenesis. Statistical analysis included ANOVA, T -test, and Mann–Whitney U test (significance p < 0.05). Results: At 14 days, inflammatory cell infiltration differed significantly among groups ( p = 0.019), with the PLLA-chitosan patch showing the lowest inflammatory cell count. By 56 days, inflammation had subsided in all groups ( p = 0.989). Initial fibrous capsule thickness at 14 days was higher in the heparin-coated group and differed significantly among groups ( p = 0.019), but by 56 days all groups showed stable fibrous encapsulation with no significant differences ( p = 0.916). All implants supported neovascularization, with evidence of new blood vessel formation (angiogenesis) around the patch materials. No excessive fibrous tissue formation or cytotoxic effects were observed in any group. Conclusion: The heparin-coated PLLA-chitosan patch displayed good biocompatibility, modulating inflammation, and supporting neovascularization. These findings suggest its potential as a vascular graft for large vessel reconstruction, though further long-term studies are needed.
- 18 January 2026
- Published by SAGE Publications in The International Journal of Artificial Organs
- Vol. 49 (1) , 47-54
Biocompatibility of heparin-coated PLLA-chitosan patch potentially usable for large blood vessel reconstruction: A Wistar rat histological study
Introduction: Stroke remains a leading cause of disability and death globally, with carotid stenosis as a major contributor. Carotid endarterectomy with patch angioplasty reduces restenosis risk, but current patch materials often lack biocompatibility and biodegradability. This study introduces a novel vascular patch composed of poly-L-lactic acid (PLLA) and chitosan, coated with heparin, designed to promote tissue integration and safe degradation. Method: A true experimental in vivo study was conducted using 54 Wistar rats, divided into three groups: (1) PLLA scaffold (Group K1/K2), (2) PLLA-chitosan scaffold (Group P1/P3), and (3) PLLA-chitosan with heparin coating scaffold (Group P2/P4). Histological analyses at 14 and 56 days post-implantation evaluated inflammatory response, fibrous capsule formation, and angiogenesis. Statistical analysis included ANOVA, T -test, and Mann–Whitney U test (significance p < 0.05). Results: At 14 days, inflammatory cell infiltration differed significantly among groups ( p = 0.019), with the PLLA-chitosan patch showing the lowest inflammatory cell count. By 56 days, inflammation had subsided in all groups ( p = 0.989). Initial fibrous capsule thickness at 14 days was higher in the heparin-coated group and differed significantly among groups ( p = 0.019), but by 56 days all groups showed stable fibrous encapsulation with no significant differences ( p = 0.916). All implants supported neovascularization, with evidence of new blood vessel formation (angiogenesis) around the patch materials. No excessive fibrous tissue formation or cytotoxic effects were observed in any group. Conclusion: The heparin-coated PLLA-chitosan patch displayed good biocompatibility, modulating inflammation, and supporting neovascularization. These findings suggest its potential as a vascular graft for large vessel reconstruction, though further long-term studies are needed.
- Open Access
- 9 January 2026
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 17, 11
Effectiveness of the combination of bovine scaffold and autologous calvarial bone dust in burr hole defect closure post-osteoplasty
Background: Craniotomy involves creating multiple burr holes followed by the opening of a bone flap. After the intracranial procedure, the bone flap is replaced (osteoplasty), but burr hole defects remain and may lead to scalp depressions over time. This study evaluates the effectiveness of using a graft combination of bovine scaffold material and autologous calvarial bone dust for burr hole defect closure in calvarial osteoplasty. Methods: The scaffold was derived from the epiphysis of bovine cancellous femur bone, prepared by the tissue bank of Dr. Soetomo General Hospital, and adjusted to fit burr hole defects. Four patients underwent grafting with this combination during osteoplasty. All patients were followed up and evaluated at least 1 year after graft placement. Clinical assessment focused on scalp depressions, while head computed tomography (CT) scans were used to evaluate bone integration between the calvarial bone and the graft. Results: Among four patients, one showed scalp depression at the graft site, while the other three had no visible indentations. CT scans demonstrated that the three cases without scalp depression have intact grafts with cortical thickening in some areas. The single case with depression exhibited graft resorption and lytic bone changes. Importantly, no signs of graft rejection or allergic reactions were observed in any patient. Conclusion: This study suggests that the combination of bovine scaffold material and autologous calvarial bone dust in burr hole defect closure during calvarial osteoplasty can prevent scalp depression in the defect area.
- 9 January 2026
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 17, 11
Open AccessEffectiveness of the combination of bovine scaffold and autologous calvarial bone dust in burr hole defect closure post-osteoplasty
Background: Craniotomy involves creating multiple burr holes followed by the opening of a bone flap. After the intracranial procedure, the bone flap is replaced (osteoplasty), but burr hole defects remain and may lead to scalp depressions over time. This study evaluates the effectiveness of using a graft combination of bovine scaffold material and autologous calvarial bone dust for burr hole defect closure in calvarial osteoplasty. Methods: The scaffold was derived from the epiphysis of bovine cancellous femur bone, prepared by the tissue bank of Dr. Soetomo General Hospital, and adjusted to fit burr hole defects. Four patients underwent grafting with this combination during osteoplasty. All patients were followed up and evaluated at least 1 year after graft placement. Clinical assessment focused on scalp depressions, while head computed tomography (CT) scans were used to evaluate bone integration between the calvarial bone and the graft. Results: Among four patients, one showed scalp depression at the graft site, while the other three had no visible indentations. CT scans demonstrated that the three cases without scalp depression have intact grafts with cortical thickening in some areas. The single case with depression exhibited graft resorption and lytic bone changes. Importantly, no signs of graft rejection or allergic reactions were observed in any patient. Conclusion: This study suggests that the combination of bovine scaffold material and autologous calvarial bone dust in burr hole defect closure during calvarial osteoplasty can prevent scalp depression in the defect area.
- Open Access
- 12 December 2025
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 16, 528
Different methods of cerebrospinal fluid diversion in patients with leptomeningeal metastasis: A systematic review and meta-analysis
Background: Leptomeningeal metastasis (LM) is one of the complications of primary malignancies, particularly in solid tumors. The consequence of LM is increased intracranial pressure (ICP) or secondary hydrocephalus. The most frequent method for diverting cerebrospinal fluid (CSF) in this group is a ventriculoperitoneal shunt (VPS); however, the capability of CSF diversion in improving patients’ survival has been debatable. There is currently no established protocol for treating LM patients with elevated ICP. Methods: We searched for studies involving patients with LM who underwent CSF diversion in multiple search databases. The search flow followed the Preferred Reporting Items for Systematic Review and Meta-Analysis Protocol criteria. Results: This review includes a total of 15 studies. The average age at diagnosis was 55.3 ± 3.9 years. Among 415 patients, lung cancer was the most frequent primary malignancy. Overall symptom improvement from CSF diversion is 86% (95% confidence interval [CI]: 0.79–0.92). Complication rate among patients who had permanent CSF diversion is 18% (95% CI: 0.11.24). Overall survival in the LM population can be improved by permanent CSF diversion ( P < 0.05). The superiority of the lumboperitoneal shunt over VPS in improving survival is yet to be determined due to a lack of statistically significant findings. Although the use of permanent CSF diversion in conjunction with reservoir devices is increasing, its superiority in improving survival has not yet been established. Conclusion: This review demonstrated that patients with LM may benefit from a higher chance of survival with permanent CSF diversion. Further research is required to determine the role of various CSF diversion methods in improving survival.
- 12 December 2025
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 16, 528
Open AccessDifferent methods of cerebrospinal fluid diversion in patients with leptomeningeal metastasis: A systematic review and meta-analysis
Background: Leptomeningeal metastasis (LM) is one of the complications of primary malignancies, particularly in solid tumors. The consequence of LM is increased intracranial pressure (ICP) or secondary hydrocephalus. The most frequent method for diverting cerebrospinal fluid (CSF) in this group is a ventriculoperitoneal shunt (VPS); however, the capability of CSF diversion in improving patients’ survival has been debatable. There is currently no established protocol for treating LM patients with elevated ICP. Methods: We searched for studies involving patients with LM who underwent CSF diversion in multiple search databases. The search flow followed the Preferred Reporting Items for Systematic Review and Meta-Analysis Protocol criteria. Results: This review includes a total of 15 studies. The average age at diagnosis was 55.3 ± 3.9 years. Among 415 patients, lung cancer was the most frequent primary malignancy. Overall symptom improvement from CSF diversion is 86% (95% confidence interval [CI]: 0.79–0.92). Complication rate among patients who had permanent CSF diversion is 18% (95% CI: 0.11.24). Overall survival in the LM population can be improved by permanent CSF diversion ( P < 0.05). The superiority of the lumboperitoneal shunt over VPS in improving survival is yet to be determined due to a lack of statistically significant findings. Although the use of permanent CSF diversion in conjunction with reservoir devices is increasing, its superiority in improving survival has not yet been established. Conclusion: This review demonstrated that patients with LM may benefit from a higher chance of survival with permanent CSF diversion. Further research is required to determine the role of various CSF diversion methods in improving survival.
- Open Access
- 30 September 2025
- Published by Universitas Airlangga in Journal of Public Health Research and Community Health Development
- Vol. 9 (1) , 97-104
EDUCATION REGARDING EARLY DETECTION AND EARLY TREATMENT OF BRAIN TUMORS IN BANYUWANGI REGENCY, INDONESIA
Brain tumors were estimated to occur at 6.4 per 100,000 people each year. The incidence rate of brain tumors in children is reported to be 5.7% out of every 100,000 children, while in adults, the reported rate is significantly higher at 29.9% out of every 100,000 people. Banyuwangi Regency has an area of 5,782.50 km2 with a population in 2018 of 1,609,677 people with a density of around 278 people/km2. With such a large population, early detection of brain tumors is important for the public to understand. Early detection activity programs from community health centre need to be held with the hope that health workers will be able to provide education and information regarding early symptoms and signs of brain tumors as well as risk factors for brain tumors for prevention. Increasing public knowledge about alerting the early symptoms of brain tumors is one strategy that can be used to reduce death and disability rates due to brain tumors. The aim of this community service program is to increase the knowledge of the lay public and health workers regarding early detection and early treatment of brain tumors in Banyuwangi Regency. Pre- and post-test questionnaires were given before and after the material to evaluate the increase in knowledge about brain tumors for lay people and health workers in Banyuwangi Regency. The results obtained a significant increase (p < 0.01) between the pre-test and post-test scores so that this community service increases the knowledge of the community in Banyuwangi Regency.
- 30 September 2025
- Published by Universitas Airlangga in Journal of Public Health Research and Community Health Development
- Vol. 9 (1) , 97-104
Open AccessEDUCATION REGARDING EARLY DETECTION AND EARLY TREATMENT OF BRAIN TUMORS IN BANYUWANGI REGENCY, INDONESIA
Brain tumors were estimated to occur at 6.4 per 100,000 people each year. The incidence rate of brain tumors in children is reported to be 5.7% out of every 100,000 children, while in adults, the reported rate is significantly higher at 29.9% out of every 100,000 people. Banyuwangi Regency has an area of 5,782.50 km2 with a population in 2018 of 1,609,677 people with a density of around 278 people/km2. With such a large population, early detection of brain tumors is important for the public to understand. Early detection activity programs from community health centre need to be held with the hope that health workers will be able to provide education and information regarding early symptoms and signs of brain tumors as well as risk factors for brain tumors for prevention. Increasing public knowledge about alerting the early symptoms of brain tumors is one strategy that can be used to reduce death and disability rates due to brain tumors. The aim of this community service program is to increase the knowledge of the lay public and health workers regarding early detection and early treatment of brain tumors in Banyuwangi Regency. Pre- and post-test questionnaires were given before and after the material to evaluate the increase in knowledge about brain tumors for lay people and health workers in Banyuwangi Regency. The results obtained a significant increase (p < 0.01) between the pre-test and post-test scores so that this community service increases the knowledge of the community in Banyuwangi Regency.
- Open Access
- 21 February 2025
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 16, 54
Contributing factors to pain-free outcome in trigeminal neuralgia following microvascular decompression
Background: Trigeminal neuralgia (TN) is a disease that impairs patients’ daily activities. Microvascular decompression (MVD) is known as the best procedure to relieve pain, yet a small portion of patients still experience pain after surgery. This study will analyze the prognostic factor of MVD for TN patients. Methods: This is a retrospective cohort study of patients with TN who underwent MVD in an Indonesian tertiary hospital from January 2012 to December 2023. It combines medical records and patient interviews followed by statistical analysis to identify prognostic factors influencing the outcome of MVD for TN. Results: Good response to carbamazepine is a favorable factor for short-term pain-free following MVD (P = 0.01). The type of pain emerged as the sole significant prognostic indicator for short-term (P < 0.001) and long-term (P = 0.04) pain relief following MVD. The duration of pain, the type of blood vessels compressing, and the location of compression demonstrated no statistically significant prognostic value on post-MVD pain-free outcomes. Conclusion: MVD outcomes are influenced by several factors, including trigeminal pain type (for short and long-term outcomes) and response to carbamazepine (short-term outcomes). Conversely, other factors thought to influence MVD outcomes, such as the duration of pain, the type of blood vessel compressing the nerve, or the site of nerve compression, have not been proven to influence the procedure’s outcome.
- 21 February 2025
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 16, 54
Open AccessContributing factors to pain-free outcome in trigeminal neuralgia following microvascular decompression
Background: Trigeminal neuralgia (TN) is a disease that impairs patients’ daily activities. Microvascular decompression (MVD) is known as the best procedure to relieve pain, yet a small portion of patients still experience pain after surgery. This study will analyze the prognostic factor of MVD for TN patients. Methods: This is a retrospective cohort study of patients with TN who underwent MVD in an Indonesian tertiary hospital from January 2012 to December 2023. It combines medical records and patient interviews followed by statistical analysis to identify prognostic factors influencing the outcome of MVD for TN. Results: Good response to carbamazepine is a favorable factor for short-term pain-free following MVD (P = 0.01). The type of pain emerged as the sole significant prognostic indicator for short-term (P < 0.001) and long-term (P = 0.04) pain relief following MVD. The duration of pain, the type of blood vessels compressing, and the location of compression demonstrated no statistically significant prognostic value on post-MVD pain-free outcomes. Conclusion: MVD outcomes are influenced by several factors, including trigeminal pain type (for short and long-term outcomes) and response to carbamazepine (short-term outcomes). Conversely, other factors thought to influence MVD outcomes, such as the duration of pain, the type of blood vessel compressing the nerve, or the site of nerve compression, have not been proven to influence the procedure’s outcome.
- Open Access
- 12 August 2022
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 13, 361
Clear-cell renal cell carcinoma and glioblastoma multiforme coexistence: Double primary malignancy, does it have a causal relationship?
Background: Multiple primary malignancies (MPMs), especially coexistence of renal cell carcinoma (RCC) and glioblastoma multiforme (GBM), are rare. The most likely clinical diagnosis in patient with tumor in another organ is metastatic brain tumor. Although GBM is the most common brain tumor, it is rarely coexistent with other malignancies.Case Description: A 64-year-old female presented with headache and dizziness, along with abdominal pain for 2 weeks before being admitted. The abdominal computed tomography (CT) scan showed a kidney tumor. The patient developed left hemiplegia, and the brain CT scan showed an intracranial tumor. The patient suggested for radical nephrectomy and craniotomy tumor removal. Histopathology of the kidney and brain tumor revealed two different features, which showed RCC and GBM. Immunohistochemistry result confirmed the diagnosis of GBM and IDH1 wild type; coexistent with clear cell RCC.Conclusion: The coexistence of carcinoma and glioma should be regarded as coincidental cases if it did not accomplish the criteria for tumor-to-tumor metastasis or proven to be a genetic syndrome. This case report provides an addition to the literature about double primary malignancy in a single patient. More studies are needed to confirm whether they have causal relationship or merely coincidental findings.
- 12 August 2022
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 13, 361
Open AccessClear-cell renal cell carcinoma and glioblastoma multiforme coexistence: Double primary malignancy, does it have a causal relationship?
Background: Multiple primary malignancies (MPMs), especially coexistence of renal cell carcinoma (RCC) and glioblastoma multiforme (GBM), are rare. The most likely clinical diagnosis in patient with tumor in another organ is metastatic brain tumor. Although GBM is the most common brain tumor, it is rarely coexistent with other malignancies.Case Description: A 64-year-old female presented with headache and dizziness, along with abdominal pain for 2 weeks before being admitted. The abdominal computed tomography (CT) scan showed a kidney tumor. The patient developed left hemiplegia, and the brain CT scan showed an intracranial tumor. The patient suggested for radical nephrectomy and craniotomy tumor removal. Histopathology of the kidney and brain tumor revealed two different features, which showed RCC and GBM. Immunohistochemistry result confirmed the diagnosis of GBM and IDH1 wild type; coexistent with clear cell RCC.Conclusion: The coexistence of carcinoma and glioma should be regarded as coincidental cases if it did not accomplish the criteria for tumor-to-tumor metastasis or proven to be a genetic syndrome. This case report provides an addition to the literature about double primary malignancy in a single patient. More studies are needed to confirm whether they have causal relationship or merely coincidental findings.
- Open Access
- 12 July 2021
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 12, 345
Tranexamic acid to reduce operative blood loss in brain tumor surgery: A meta-analysis
Background: Major blood loss during neurosurgery may result in a variety of complications, such as potentially fatal hemodynamic instability. Brain tumor and skull base surgery is among the high bleeding risk procedures. Tranexamic acid (TXA) has been found to reduce bleeding events in various fields of medicine.Methods: We searched for all randomized controlled trials published in English or Bahasa which compared the use of TXA with placebo in brain tumor surgery. The studies should include adult patients with intracranial tumor who received TXA before skin incision. The primary and secondary outcomes are intraoperative blood loss and the need of transfusion.Results: This meta-analysis included a total of 200 patients from three studies. TXA resulted in less blood loss with pooled mean difference of −292.80 (95% CI, −431.63, −153.96,P<0.05). The need of transfusion was not significant between TXA and control group (pooled mean difference −85.36, 95% CI, −213.23 – (42.51), P=0.19).Conclusion: TXA reduced the volume of blood loss but did not reduce the need of blood transfusion.
- 12 July 2021
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 12, 345
Open AccessTranexamic acid to reduce operative blood loss in brain tumor surgery: A meta-analysis
Background: Major blood loss during neurosurgery may result in a variety of complications, such as potentially fatal hemodynamic instability. Brain tumor and skull base surgery is among the high bleeding risk procedures. Tranexamic acid (TXA) has been found to reduce bleeding events in various fields of medicine.Methods: We searched for all randomized controlled trials published in English or Bahasa which compared the use of TXA with placebo in brain tumor surgery. The studies should include adult patients with intracranial tumor who received TXA before skin incision. The primary and secondary outcomes are intraoperative blood loss and the need of transfusion.Results: This meta-analysis included a total of 200 patients from three studies. TXA resulted in less blood loss with pooled mean difference of −292.80 (95% CI, −431.63, −153.96,P<0.05). The need of transfusion was not significant between TXA and control group (pooled mean difference −85.36, 95% CI, −213.23 – (42.51), P=0.19).Conclusion: TXA reduced the volume of blood loss but did not reduce the need of blood transfusion.
- Open Access
- 28 June 2021
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 12, 306
Deadly complication of sacrificing superior petrosal vein during cerebellopontine angle tumor resection: A case report and literature review
Background: Tumors of the cerebellopontine angle (CPA) are challenging to resect and have been proven difficult for neurosurgeons to manage optimally. Superior petrosal vein complex (SPVC) as the main drainage system and close proximity to CPA could be an obstacle during operation. There is an incidence ranging from 55% to 84% of injury to one part of the SPVC during CPA tumor surgery.Case Description: We report a case of 65-year-old woman with CPA tumor, who complained of unilateral hearing loss, dizziness, and facial pain. During tumor resection, one part of SPV complex was injured, then cerebellar edema develops.Conclusion: This case provides an overview of surgical complication associated with venous sacrifice. This would support the agreement to preserve SPV regarding risks and improve the quality of surgical decision making.
- 28 June 2021
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 12, 306
Open AccessDeadly complication of sacrificing superior petrosal vein during cerebellopontine angle tumor resection: A case report and literature review
Background: Tumors of the cerebellopontine angle (CPA) are challenging to resect and have been proven difficult for neurosurgeons to manage optimally. Superior petrosal vein complex (SPVC) as the main drainage system and close proximity to CPA could be an obstacle during operation. There is an incidence ranging from 55% to 84% of injury to one part of the SPVC during CPA tumor surgery.Case Description: We report a case of 65-year-old woman with CPA tumor, who complained of unilateral hearing loss, dizziness, and facial pain. During tumor resection, one part of SPV complex was injured, then cerebellar edema develops.Conclusion: This case provides an overview of surgical complication associated with venous sacrifice. This would support the agreement to preserve SPV regarding risks and improve the quality of surgical decision making.